ICRF has awarded more than $93 million in funding to support over 2,800 grants to outstanding cancer researchers at all leading institutions in Israel as well as collaborative research partnerships between Israeli and North American investigators. Many of our grantees are responsible for major cancer research breakthroughs and discoveries.

Recipient(s) Institution Grant Type Research Topics Grant Status
Limor Broday, PhD Tel Aviv University Acceleration Grant Cell Signaling, Genetics and Genomics, Lung Cancer, Model Organisms, Oncogenesis Non-active
Michal Brunwasser-Meirom, PhD Technion, Israel Institute of Technology Postdoctoral Fellowship Experimental Therapeutics Non-active
Tal Burstyn-Cohen, PhD Hebrew University of Jerusalem Project Grant Brain Cancer, Cancer Treatment, Inhibiting Tumor Growth Active
Yaron Carmi, PhD Tel Aviv University Research Career Development Award Animal Modes of Cancer, Cancer Metastasis, Cell Signaling, Immunology and Immunotherapy, Inflammation and Cancer, Model Organisms, Skin Cancer Non-active
Howard Cedar, MD, PhD Hebrew University-Hadassah Medical School Research Professorship Grant Genetics and Genomics, Oncogenesis Non-active
Aaron Ciechanover, MD, DSc Technion, Israel Institute of Technology Research Professorship Grant Inflammation and Cancer, Oncogenesis, Ubiquitin System Active
Cyrille Cohen, PhD Bar-Ilan University ICRF-Cancer Research Institute Immunotherapy Promise Grant Blood Cancers, Cancer Metastasis, Colorectal Cancer, Gastrointestinal Cancer, Immunology and Immunotherapy, Lung Cancer, Skin Cancer Non-active
Idan Cohen, PhD Ben-Gurion University of the Negev Research Career Development Award Animal Modes of Cancer, Skin Cancer Non-active
Merav Cohen, PhD Tel Aviv University Research Career Development Award Breast Cancer, Early Detection, Immunology and Immunotherapy, Women’s Cancers Active
Haim Cohen, PhD Bar-Ilan University Aging & Cancer Int’l Collaboration Grant Aging Active